<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03134586</url>
  </required_header>
  <id_info>
    <org_study_id>ANDI 1</org_study_id>
    <nct_id>NCT03134586</nct_id>
  </id_info>
  <brief_title>Advanced Non-Invasive Diagnostics in Inflammatory Bowel Disease</brief_title>
  <acronym>ANDI</acronym>
  <official_title>A Comparative Study of the Diagnostic Validity of Ultrasound, Magnetic Resonance Imaging and Capsule Endoscopy of Both the Small and Large Intestine in Suspected Crohn's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sydvestjysk Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sygehus Lillebaelt</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Sydvestjysk Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether Non-invasive endoscopic procedures (pillcam&#xD;
      colon capsule endoscopy, PCCE) and non-ionizing radiological modalities (MR&#xD;
      enterocolonography, MREC and ultrasound, US) - offer a sufficiently high diagnostic validity&#xD;
      in patients with suspected CD compared to the traditional invasive approach using&#xD;
      ileocolonoscopy with biopsies as first line diagnostic modality&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, blinded, multicenter study of the diagnostic validity, inter-observer&#xD;
      agreement, image quality and subjective experience of discomfort with PCCE, MREC and US in&#xD;
      patients with suspected CD. Ileocolonoscopy serves as the diagnostic gold standard. Patients&#xD;
      are recruited from 3 centers in the Region of Southern Denmark managing adult patients with&#xD;
      inflammatory bowel diseases. Each patient goes through a standardized work-up including&#xD;
      medical history, physical examination, C-reactive protein, fecal calprotectin,&#xD;
      ileocolonoscopy, PCCE, MREC and US. All examinations are reviewed and described in a&#xD;
      standardized fashion. The radiologists and physicians describing PCCE, MREC, and US are&#xD;
      blinded to the findings at ileocolonoscopy and the other imaging modalities.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 2016</start_date>
  <completion_date type="Actual">October 23, 2020</completion_date>
  <primary_completion_date type="Actual">August 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Sensitivity and specificity of PCCE, MREC and US for the diagnosis of CD</measure>
    <time_frame>36 months</time_frame>
    <description>Sensitivity and specificity of PCCE, MREC and US for the diagnosis of CD located in the terminal ileum and colon (per patient &amp; per segment). Ileocolonoscopy serves as gold standard</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation of disease severity</measure>
    <time_frame>36 months</time_frame>
    <description>Correlation of disease severity assessed with PCCE, MREC, US and ileocolonoscopy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Inter-observer agreement</measure>
    <time_frame>36 months</time_frame>
    <description>Inter-observer agreement with PCCE, MREC, US and ileocolonoscopy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diagnostic yield of proximal CD</measure>
    <time_frame>36 months</time_frame>
    <description>Diagnostic yield of PCCE, MREC and US for CD located proximal to the terminal ileum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patients reported experience</measure>
    <time_frame>36 months</time_frame>
    <description>Patients' subjective experience of discomfort during PCCE, MREC, US and ileocolonoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Interobserver PCCE</measure>
    <time_frame>36 months</time_frame>
    <description>Sensitivity and specificity of PCCE with different reading protocols</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Utility of diffusion weighed magnetic resonance imaging (dw-MREC) and US Doppler flow</measure>
    <time_frame>36 months</time_frame>
    <description>Utility of diffusion weighed magnetic resonance imaging (dw-MREC) and US Doppler flow (Limberg score): Sensitivity, specificity and correlation with endoscopic disease activity</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">153</enrollment>
  <condition>Crohn Disease</condition>
  <arm_group>
    <arm_group_label>trial participant</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>All participants undergoes the same diagnostic imaging</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Diagnostic imaging</intervention_name>
    <arm_group_label>trial participant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        General criterion&#xD;
&#xD;
        All of the following:&#xD;
&#xD;
          -  Clinical suspicion of CD&#xD;
&#xD;
          -  Age &gt; 15 years&#xD;
&#xD;
          -  Negative serologic markers for celiac disease, negative stool culture (or polymerase&#xD;
             chain reaction) for pathogenic bacteria and a negative microscopy for intestinal&#xD;
             parasites&#xD;
&#xD;
          -  Fecal calprotectin &gt; 50 mg/kg&#xD;
&#xD;
          -  Signed informed consent&#xD;
&#xD;
        Clinical criterion Diarrhea and/or abdominal pain for more than 1 month (or repeated&#xD;
        episodes of diarrhea and/or abdominal pain) associated with one or more of the following&#xD;
        findings: (1) C-reactive protein (CRP) &gt;5 mg/L, (2) thrombocytosis (&gt; 400 x 109/L), anemia&#xD;
        (hemoglobin &lt; 7.0 mmol/L for women and &lt; 8.0 mmol /L for men or a decrease &gt; 0.5 mmol/L&#xD;
        compared to the usual level), (3) prolonged fever (&gt; 37.5 C for more than 2 weeks), (5)&#xD;
        weight loss (≥ 3 kg or ≥ 5% compared to the normal body weight), (6) perianal&#xD;
        abscess/fistula, or (7) a family history of inflammatory bowel disease.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Acute bowel obstruction&#xD;
&#xD;
          -  Intake of NSAIDs or acetylsalicylic acid ≤ 4 weeks before inclusion except&#xD;
             prophylactic treatment with low dose Aspirin (≤ 150 mg per day)&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Alcohol or drug abuse&#xD;
&#xD;
          -  Known gastrointestinal disorder other than inflammatory bowel disease&#xD;
&#xD;
          -  Renal failure defined by a plasma-creatinine above the normal reference range&#xD;
&#xD;
          -  Claustrophobia, cardiac pacemaker or implanted magnetic foreign bodies that precludes&#xD;
             MREC&#xD;
&#xD;
          -  Interpreter required or inability to understand the oral and written information&#xD;
&#xD;
          -  Colonoscopy contraindicated, performed within 3 months or unwillingness to go through&#xD;
             colonoscopy&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob B Brodersen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sydvestjysk Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Sydvestjysk sygehus</name>
      <address>
        <city>Esbjerg</city>
        <zip>DK-6700</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Odense university Hospital</name>
      <address>
        <city>Odense</city>
        <zip>DK-5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sygehus Lillebaelt</name>
      <address>
        <city>Vejle</city>
        <zip>DK-7100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>January 6, 2017</study_first_submitted>
  <study_first_submitted_qc>April 25, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2017</study_first_posted>
  <last_update_submitted>October 23, 2020</last_update_submitted>
  <last_update_submitted_qc>October 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sydvestjysk Hospital</investigator_affiliation>
    <investigator_full_name>Jacob Brodersen</investigator_full_name>
    <investigator_title>Specialist Registrat</investigator_title>
  </responsible_party>
  <keyword>Capsule endoscopy</keyword>
  <keyword>Crohn's disease</keyword>
  <keyword>Magnetic resonance enterography</keyword>
  <keyword>Ileocolonoscopy</keyword>
  <keyword>Bowel Ultrasound</keyword>
  <keyword>diagnostic imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Crohn Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

